Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5080381
Max Phase: Preclinical
Molecular Formula: C41H68N12O9
Molecular Weight: 873.07
Molecule Type: Unknown
Associated Items:
ID: ALA5080381
Max Phase: Preclinical
Molecular Formula: C41H68N12O9
Molecular Weight: 873.07
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
Standard InChI: InChI=1S/C41H68N12O9/c1-23(2)21-31(37(58)49-25(4)34(55)47-24(3)33(54)48-26(5)35(56)51-30(40(61)62)16-11-19-46-41(44)45)52-38(59)32-17-12-20-53(32)39(60)29(15-9-10-18-42)50-36(57)28(43)22-27-13-7-6-8-14-27/h6-8,13-14,23-26,28-32H,9-12,15-22,42-43H2,1-5H3,(H,47,55)(H,48,54)(H,49,58)(H,50,57)(H,51,56)(H,52,59)(H,61,62)(H4,44,45,46)/t24-,25-,26-,28-,29-,30-,31-,32-/m0/s1
Standard InChI Key: KTXAEFBBMKNZQD-FGTNARQOSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 873.07 | Molecular Weight (Monoisotopic): 872.5232 | AlogP: -1.96 | #Rotatable Bonds: 26 |
Polar Surface Area: 346.15 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 21 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 4.04 | CX Basic pKa: 11.57 | CX LogP: -3.97 | CX LogD: -6.92 |
Aromatic Rings: 1 | Heavy Atoms: 62 | QED Weighted: 0.03 | Np Likeness Score: 0.09 |
1. Gorman DM, Li XX, Lee JD, Fung JN, Cui CS, Lee HS, Rolfe BE, Woodruff TM, Clark RJ.. (2021) Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity., 64 (22.0): [PMID:34762432] [10.1021/acs.jmedchem.1c01174] |
Source(1):